Lothar Huebsch

2.5k total citations
73 papers, 1.5k citations indexed

About

Lothar Huebsch is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lothar Huebsch has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 25 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Lothar Huebsch's work include Hematopoietic Stem Cell Transplantation (32 papers), Lymphoma Diagnosis and Treatment (13 papers) and Viral-associated cancers and disorders (8 papers). Lothar Huebsch is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Lymphoma Diagnosis and Treatment (13 papers) and Viral-associated cancers and disorders (8 papers). Lothar Huebsch collaborates with scholars based in Canada, United States and Saudi Arabia. Lothar Huebsch's co-authors include Sheryl McDiarmid, Christopher Bredeson, David Allan, Jason Tay, Dean Fergusson, Isabelle Bence‐Bruckler, Harold Atkins, Benoît Leclair, Alan Tinmouth and Mitchell Sabloff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Lothar Huebsch

70 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lothar Huebsch Canada 21 674 361 217 209 192 73 1.5k
Henrik Gregersen Denmark 23 727 1.1× 395 1.1× 136 0.6× 270 1.3× 47 0.2× 70 1.7k
Aleksandar Radujkovic Germany 18 471 0.7× 191 0.5× 244 1.1× 268 1.3× 56 0.3× 53 1.3k
Helga Radner Austria 26 543 0.8× 106 0.3× 416 1.9× 287 1.4× 87 0.5× 69 2.4k
Jennifer Schneiderman United States 15 732 1.1× 180 0.5× 484 2.2× 92 0.4× 81 0.4× 45 1.9k
Hèctor Corominas Spain 21 194 0.3× 161 0.4× 174 0.8× 177 0.8× 73 0.4× 168 1.4k
Jasmina Ahluwalia India 19 534 0.8× 83 0.2× 137 0.6× 112 0.5× 98 0.5× 162 1.2k
Salahuddin Kazi United States 13 327 0.5× 106 0.3× 368 1.7× 216 1.0× 102 0.5× 24 1.5k
C.J. Haagsma Netherlands 20 855 1.3× 121 0.3× 479 2.2× 312 1.5× 91 0.5× 38 2.8k
Heather Hume Canada 25 1.4k 2.1× 221 0.6× 335 1.5× 85 0.4× 79 0.4× 62 3.2k
Anke M. van Gestel Netherlands 17 1.3k 1.9× 198 0.5× 605 2.8× 582 2.8× 140 0.7× 24 3.7k

Countries citing papers authored by Lothar Huebsch

Since Specialization
Citations

This map shows the geographic impact of Lothar Huebsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Huebsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Huebsch more than expected).

Fields of papers citing papers by Lothar Huebsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Huebsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Huebsch. The network helps show where Lothar Huebsch may publish in the future.

Co-authorship network of co-authors of Lothar Huebsch

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Huebsch. A scholar is included among the top collaborators of Lothar Huebsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Huebsch. Lothar Huebsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Heidi Oi‐Yee, Christophe L. Herry, Nathan Scales, et al.. (2021). Early Warning of Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation Using Heart Rate Variability and Serum Biomarkers. Transplantation and Cellular Therapy. 28(3). 166.e1–166.e8. 7 indexed citations
2.
Aw, Andrew, Lisa Duffett, Lothar Huebsch, et al.. (2021). To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report. Clinical Lymphoma Myeloma & Leukemia. 21(6). e493–e496. 1 indexed citations
4.
Mallick, Ranjeeta, Adam Bryant, Harold Atkins, et al.. (2020). Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?. Biology of Blood and Marrow Transplantation. 26(7). 1298–1302. 13 indexed citations
5.
Savoie, Mary Lynn, Isabelle Bence‐Bruckler, Lothar Huebsch, et al.. (2018). Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era. Leukemia Research. 73. 67–75.
7.
Samant, Rajeev S., Mitchell Sabloff, Christopher Bredeson, et al.. (2016). PO-0667: Second malignancies after TBI in AHCT for relapsed follicular lymphoma. Radiotherapy and Oncology. 119. S311–S311. 5 indexed citations
8.
Sheppard, Dawn, Jason Tay, Douglas S. Palmer, et al.. (2015). Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach. Biology of Blood and Marrow Transplantation. 22(4). 763–767. 8 indexed citations
9.
Ahmad, Saif, Tim Ramsay, Lothar Huebsch, et al.. (2009). Continuous Multi-Parameter Heart Rate Variability Analysis Heralds Onset of Sepsis in Adults. PLoS ONE. 4(8). e6642–e6642. 194 indexed citations
10.
Samant, Rajiv, et al.. (2009). Comparison of Favorable Early-Stage Hodgkin's Lymphoma Treatments: A Single-Institution Review. International Journal of Radiation Oncology*Biology*Physics. 76(4). 1166–1170. 2 indexed citations
12.
Iqbal, Tariq, Lin Yang, Antonio Giulivi, et al.. (2008). Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation. Experimental Hematology. 36(4). 506–512. 5 indexed citations
13.
Sabloff, Mitchell, Sheryl McDiarmid, Harold Atkins, et al.. (2006). A 15-year review of autologous stem cell transplant of advanced relapsed follicular lymphoma at the Ottawa hospital. Biology of Blood and Marrow Transplantation. 12(2). 115–115. 1 indexed citations
14.
Bredeson, Christopher, Chantal S. Leger, Stephen Couban, et al.. (2004). An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biology of Blood and Marrow Transplantation. 10(6). 405–414. 46 indexed citations
15.
Bredeson, Christopher, George Perry, Sheryl McDiarmid, et al.. (2002). Outpatient total body irradiation as a component of a comprehensive outpatient transplant program. Bone Marrow Transplantation. 29(8). 667–671. 8 indexed citations
16.
Schimmer, Aaron D., Shahin Jamal, Hans A. Messner, et al.. (2000). Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin’s lymphoma (NHL): results of a provincial strategy. Bone Marrow Transplantation. 26(8). 859–864. 51 indexed citations
17.
Bredeson, Christopher, et al.. (2000). Autologous blood and marrow transplantation in patients 60 years and older. Biology of Blood and Marrow Transplantation. 6(2). 204–210. 23 indexed citations
19.
Huebsch, Lothar, et al.. (1996). Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13‐year followup. Arthritis & Rheumatism. 39(7). 1246–1253. 98 indexed citations
20.
Huebsch, Lothar. (1981). Progress in Pediatric Hematology/Oncology.. Canadian Medical Association Journal. 125(6). 609–609. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026